• Exploring effectiveness of supply chain security

    Businesses have been taking greater strides to protect their supply chains since the 9/11 terrorist attacks; new study finds that having a clear supply chain security strategy is far more valuable in perceived effectiveness than either availability of resources or management support

  • Aethlon Medical says its Hemopurifier can serve in counter-bioterror applications

    Aethlon Medical says its Hemopurifier says the device is the first medical device selectively to target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system, and as such it is the most advanced and perhaps the only true broad-spectrum countermeasure against viral threats most likely to be weaponized against civilian and military populations

  • CDC says U.S. prepared to investigate urgent disease reports

    CDC recently released a new report that found that all fifty states have the ability to investigate urgent disease reports, including bioterror attacks, twenty-four hours a day, seven days a week

  • U.S. training developing world's docs to detect outbreaks earlier

    U.S.-funded program helps health workers in developing countries track disease and speed response to outbreaks; the CDC has established 35 programs since 1980, mostly in developing countries, with funding from several U.S. government agencies and nongovernmental organizations, and has 11 more in the works. Participants investigated 216 outbreaks in 2009

  • Vaccine work offers protection against weaponized plague bacteria

    Plague has been used as a weapon since the Middle Ages, when armies would hurl plague-infested bodies over castle walls; more recently, the United States, Japan, and the former Soviet Union have all studied the use of Y. pestis as a biological warfare agent; new research on the immune system’s response to plague could improve efforts to vaccinate the public against the world’s oldest form of biological warfare

  • New $186.6 million contract shows anthrax threat real

    In an indication that the threat of an anthrax outbreak as a result of bioterrorism remains a major priority for the Obama administration, Maryland-based Emergent BioSolutions received a contract valued at up to $186.6 million from the Department of Health and Human Services to develop a recombinant protective antigen anthrax vaccine, which is likely to produce a more rapid response to anthrax infection than existing vaccines

  • Work begins on the new U.S. premier BioLab

    DHS has released $40 million to allow work to begin on the U.S. new National Bio and Agro-Defense Facility, located on the campus of Kansas State University; the lab will replace the aging lab on Plum Island as the premier research center to combat the threat of naturally occurring animal diseases or agroterrorism; the Levl 4 BioLab will conduct research on human and animal disease to which there is yet no known cure

  • Day of synthetic pathogens-based bioterrorism nears

    Scientists have been engineering genetic sequences for decades and commercial gene sequencing has been around for years — but this year, researchers for the first time were able to design and produce cells that do not exist in nature without using pre-existing biological matter — marking the latest evolution in the rapidly advancing field of synthetic biology; the developments could pave the way for advancements in medicine, energy, and agriculture, but also could put sensitive materials in the wrong hands; it will soon be possible to recreate bacterial pathogens like smallpox — and even enhance these pathogens, making them more potent

  • Researchers develop next generation antibiotics to combat drug-resistant "superbugs"

    Each year 90,000 people in the United States die of drug-resistant “superbugs” — bacteria like Staphylococcus aureus (MRSA), a deadly form of staph infection resistant to normal antibiotics; certain bacterial strains include enzymes which help the bacteria to inactivate antibiotics — and a team of researchers are working on turning this powerful mechanism against the bacteria itself

  • Docs: drug-resistant superbug is "time bomb" requiring global response

    Researchers warn that the spread of a drug-resistant bacterial gene could herald the end of antibiotics; the bleak prediction follows his research into a drug-resistant bacterial gene called NDM-1, or New Delhi metallo-beta-lactamase 1, which was first identified in India; the bug was found attached to E.coli bacteria, but the enzyme can easily jump from one bacterium to another and experts fear it will start attaching itself to more dangerous diseases causing them to become resistant to antibiotics

  • 395 medicines and Vaccines in development to fight infectious diseases

    More than 9.5 million people worldwide die each year from infectious diseases; in the United States, two million drug-resistant infections are reported each year, causing great suffering and costing the health system up to $34 billion a year; America’s biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review

  • U.K. funds £12 million project for quick detection of farm-based disease

    A new device will be able to detect a variety of different infections, making it useful for outbreaks of human diseases, as well as animal ones; by providing a fast verdict on whether an area such as a farm is subject to an outbreak and needs to be quarantined, it could help stop the spread of the disease

  • Passenger causing Thursday airport shutdown was at center of 2003 plague scare

    A passenger on a flight back from Saudi Arabia appeared to be carrying a suspicious canister — and TSA security checkers became even more alarmed when they realized that the passenger was the scientist who sparked a bioterrorism scare after he reported missing vials of plague samples in 2003; between 100 and 200 passengers were evacuated from four of the airport’s six concourses; airport roadways and a hotel near the airport’s international terminal were closed down

  • Japan reports its first case of NDM-1 superbug

    Japan reported the first case of NDM-1 “superbug”” infection; the case follows a warning from the World Health Organization (WHO) last month calling on global health authorities to monitor the drug-resistant superbug that is believed to have spread from India

  • Seafood stewardship questionable: experts

    The world’s most established fisheries certifier — the Marine Stewardship Council (MSC) — is failing on its promises as rapidly as it gains prominence, according the world’s leading fisheries experts; “The MSC is supposed to be a solution, but a lot of what they do has turned against biology in favor of bureaucracy,” says one expert